Consistent with previous reports9,36,37, approximately half of AML samples were sensitive, whereas cells with TP53 mutations and several cell lines with wild-type TP53 were resistant to DS-5272 (Supplementary Fig. 11A, Supplementary Table 1). The gene discussed is TP53; the disease is acute myeloid leukemia.